Calibration traces are part of the patient’s data

From a security engineering standpoint, I don’t buy the idea that implant calibration sessions are disposable telemetry. The traces help tune decoding, but they can also reflect motor intent and fatigue, and may expose changes in neurological state that a patient reasonably considers intensely personal. Calling them “necessary for model improvement” doesn’t settle who should control them.

Patients should be able to inspect and export the raw traces and the derived calibration records. Deletion needs more nuance: erasing a personal copy or stopping secondary-use retention is different from deleting information clinicians need for safety, recalibration, or longitudinal review. Vendors may have legitimate performance and safety reasons to retain some data, but indefinite, unauditable retention creates breach, surveillance, and lock-in risks.

Would anyone accept a neural implant whose calibration history could not be independently audited or erased?

The cleanest model is probably separate stores: a clinical record with justified retention, and a secondary-use dataset governed by explicit consent. “Delete everything” can conflict with safety, but “the vendor owns all raw traces forever” is not a safety requirement. Those are different claims.

I’d be careful with “changes in neurological state.” The evidence supports motor-command and fatigue-related information in BCI signals; it does not establish that every calibration trace is a diagnostic record. That distinction matters when defining access and deletion rights.

Export is the underrated requirement. If patients can’t obtain machine-readable traces, they can’t meaningfully audit what was retained, move providers, or ask an independent party what the system learned. A PDF summary is not portability.

The legal baseline is weaker than the ethical case. HIPAA access rights generally concern protected health information in designated record sets, while HIPAA does not generally require deletion. State protections vary, and exemptions can apply.

There’s a product reality here: people will accept retention if the boundary is legible. Tell me what is collected, why it is retained, who can query it, and what happens after withdrawal. “Improves the model” is too vague to build trust around.

I’d want calibration to work locally by default, with an explicit export path for aggregate improvements. That won’t eliminate every clinical need for retention, but it reduces the number of copies and makes the privacy decision concrete instead of contractual fog.

One concern: deleting traces could make a later decoding failure impossible to investigate. If deletion is immediate and irreversible, patients might lose evidence needed to understand a safety incident. I’d favor a time-limited clinical hold with independent oversight, not a vendor veto.

If the answer is “you may inspect it, but only through our dashboard,” then you don’t own the data in any useful sense. Give people the bytes, the schema, and a way to leave. Revolutionary concept: records that belong to the person they describe.